Honeybee royal jelly and nobiletin stimulate CRE-mediated transcription in ERK-independent and -dependent fashions, respectively, in PC12D cells

Journal of Pharmacological Sciences

Volumn 116, Issue 4, 2011, Pages 384-387

  Fujiwara, Hironori ^a   Kogure, Ako ^a   Sakamoto, Masahiro ^a   Yamakuni, Tohru ^a   Mimaki, Yoshihiro ^b   Murata, Kiyoshi ^c   Hitomi, Nobuyuki ^c   Yamaguchi, Kikuji ^a,d,e   Ohizumi, Yasushi ^a,f,g  

^a TOHOKU UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^c R and D Center   (Japan)

^d Japan Royal Jelly (JRJ) Co Ltd   (Japan)

^e YUNNAN AGRICULTURAL UNIVERSITY   (China)

^f YOKOHAMA COLLEGE OF PHARMACY   (Japan)

^g UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Alzheimer's disease; CRE mediated transcription; Honeybee royal jelly

Indexed keywords

CRE RECOMBINASE; MITOGEN ACTIVATED PROTEIN KINASE; NOBILETIN; ROYAL JELLY;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME PHOSPHORYLATION; HONEYBEE; TRANSCRIPTION REGULATION;

EID: 84860412128     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11001SC     Document Type: Article

References (15)

1. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science. 2002;297:353-356. (Pubitemid 34790756)
2. Gong B., Vitolo O.V., Trinchese F., Liu S., Shelanski M., Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest. 2004;114:1624-1634. (Pubitemid 40385553)
3. Impey S., Mark M., Villacres E.C., Poser S., Chavkin C., Storm D.R. Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron. 1996;16:973-982.
4. Fujiwara H., Yamakuni T., Ueno M., Ishizuka M., Shinkawa T., Ohizumi Y., et al. IC101 induces apoptosis by Akt dephosphorylation via an inhibition of heat shock protein 90-ATP binding activity accompanied by preventing the interaction with Akt in L1210 cells. J Pharmacol Exp Ther. 2004;310:1288-1295. (Pubitemid 39108952)
5. 2 arrest by the inhibition of cytokinesis. Cancer Lett. 2004;209:223-229.
6. Ohizumi Y. Application of physiologically active substances isolated from natural resources to pharmacological studies. Jpn J Pharmacol. 1997;73:263-289. (Pubitemid 27226159)
7. Liu J. FK506 and cyclosporin: Molecular probes for studying intracellular signal transduction. Trends Pharmacol Sci. 1993;14:182-188. (Pubitemid 23168862)
8. Hove S.R., Dimick P.S., Benton A.W. Composition of freshly harvested and commercial royal jelly. J Apic Res. 1985;24:52-61.
9. Tokunaga K.H., Yoshida C., Suzuki K.M., Maruyama H., Futamura Y., Mishima S., et al. Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats. Biol Pharm Bull. 2004;27:189-192. (Pubitemid 41694696)
10. Miyata T. Pharmacological basis of traditional medicines and health supplements as curatives. J Pharmacol Sci. 2007;103:127-131. (Pubitemid 46294640)
11. Nagase H., Omae N., Omori A., Nakagawasai O., Tadano T., Ohizumi Y., et al. Nobiletin and its related flavonoids with CRE-dependent transcription- stimulating and neuritegenic activities. Biochem Biophys Res Commun. 2005;337:1330-1336. (Pubitemid 41505268)
12. Nakajima A., Yamakuni T., Haraguchi M., Tadano T., Mimaki Y., Ohizumi Y., et al. Nobiletin, a citrus flavonoid that improves memory impairment, rescues bulbectomy-induced cholinergic neurodegeneration in mice. J Pharmacol Sci. 2007;105:122-126. (Pubitemid 47463532)
13. Yamaguchi K. Innovation of natural beekeeping and quality control of bee products for promising apiculture. 1. Current problems of beekeeping and recurrence of natural bee-culture for resolution of the problems. J Yunnan Agric Univ. 2004;19:322-329.
14. Hattori N., Nomoto H., Mishima S., Inagaki S., Goto M., Furukawa S., et al. Identification of AMP N1-oxide in royal jelly as a component neurotrophic toward cultured rat pheochromocytoma PC12 cells. Biosci Biotechnol Biochem. 2006;70:897-906.
15. Al Rahim M., Nakajima A., Saigusa D., Tetsu N., Ohizumi Y., Yamakuni T., et al. 4′-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade. Biochemistry. 2009;48:7713-7721.